{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:11:56Z","timestamp":1788361916228,"version":"build-2803163510"},"reference-count":57,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:p>Increased bone fragility after menopause is commonly associated with accelerated bone loss and aggressive osteoclastic function. This is attributed to increased RANKL production and impaired osteoprotegerin synthesis. Fast bone loss leads to trabecular perforations, dramatic diminution of bone strength, and unexpected fractures. To avoid osteoporotic fractures, elimination of fast bone loss is recommended. Antiosteoclastic drugs, apart from estrogens, are the selective estrogen receptor modulators, calcitonins, and amino\u2010bisphosphonates. These drugs increase bone mass by 1\u20135%, but reduce the relative risk of a vertebral fracture by 30\u201370%. Long\u2010term exposure to bisphosphonates may be related to low bone turnover. In elderly and severe osteoporosis, antiosteoclastic regimens hardly correct the depressed osteoblastic function. Intermittent teriperatide stimulates osteoblastic function, improves bone geometry, and has an additional analgesic effect. While both anticatabolic and anabolic agents increase bone mass and decrease the risk of spinal fractures and occasionally of the fracture of the femoral neck, there are differences in the mode of their action. These pathophysiological differences are tentative therapeutic tools for the prevention of osteoporotic fractures. A fast bone loss, associated with increased biochemical markers, is the main indicator for anticatabolic agents, while impaired bone geometry, normal or low bone markers, and established bone architectural changes are in favor of the anabolic agents. Strontium ranelate combines the anticatabolic effect with an additional anabolic action.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2010.05666.x","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T02:08:16Z","timestamp":1284516496000},"page":"277-283","source":"Crossref","is-referenced-by-count":34,"title":["Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis"],"prefix":"10.1111","volume":"1205","author":[{"given":"George P.","family":"Lyritis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Georgoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos P","family":"Zafeiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukaryotGeneExpr.v13.i1.30"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.21.2.115"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070407"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0014"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken165"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra053077"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.07.006"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111663200"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81558-5"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03398"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012098652-1.50106-2"},{"key":"e_1_2_8_13_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/B978-012098652-1.50129-3","volume-title":"Principles of Bone Biology","author":"Hock J.","year":"2002"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007740170004"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21331"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1443.016"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.12.7840"},{"key":"e_1_2_8_18_2","first-page":"126","volume-title":"Principles of Bone Biology","author":"Takahashi N.","year":"2002"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.03.018"},{"key":"e_1_2_8_20_2","first-page":"961","volume-title":"Principles of Bone Biology","author":"Horowitz M.C.","year":"2002"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1346.019"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11468"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.06.005"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.23.3.0465"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0452-7"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-002-1345-4"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01764.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i3.40"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/60.9.883"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0540-8"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.14.1344"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040325"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.2165\/0003495-200868180-00012"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0651-5_17"},{"key":"e_1_2_8_37_2","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/endo.142.10.8437","article-title":"Have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats","volume":"10","author":"Kostenuik P.J.","year":"2001","journal-title":"Endocrinology"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"e_1_2_8_39_2","first-page":"1344","article-title":"Monitoring pharmacological therapy for osteoporosis","author":"Lewiecki M.E.","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00457-5"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0560-z"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113989"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080301"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2006.03.004"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ar.10014"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02323.x"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.11.1932"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.10.1846"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03549782"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.03.003"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.1.157"},{"key":"e_1_2_8_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022436"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1774"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2758"},{"issue":"1","key":"e_1_2_8_55_2","first-page":"S29","article-title":"8\u2010years efficacy on vertebral and non\u2010vertebral fractures in post\u2010menopausal osteoporotic women","volume":"19","author":"Reginster J.\u2010Y.","year":"2008","journal-title":"Osteoporos. Int."},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken166"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23461"},{"key":"e_1_2_8_58_2","unstructured":"Servier. Protelos.2009. Available at:http:\/\/www.servier.co.uk\/pdfs\/Protelos_SPC.pdf. Accessed March 20."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2010.05666.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2010.05666.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T04:47:30Z","timestamp":1695617250000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2010.05666.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1749-6632.2010.05666.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05666.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}